Barclays Sticks to Their Buy Rating for Patterson-UTI (PTEN)
Barclays analyst Eddie Kim maintained a Buy rating on Patterson-UTI (PTEN – Research Report) today and set a price target of $11.00. The ...
Patterson-UTI: High Torque To Increased Natural Gas Activity
Patterson-UTI’s earnings were impacted by impairments but still shows strong cash flow. Find out why PTEN stock is a BUY with ...
Zacks.com on MSN8d
Patterson-UTI (PTEN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Patterson-UTI (PTEN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...
Patterson-UTI Energy, Inc. (NASDAQ:PTEN) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are covering the company, Ratings ...
Goldman Sachs Remains a Buy on Patterson-UTI (PTEN)
In a report released today, Atidrip Modak from Goldman Sachs maintained a Buy rating on Patterson-UTI (PTEN – Research Report), with a price ...
News Medical on MSN7d
Study uncovers how MAGE-4 and Pten loss promote aggressive tumor growth
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination.
Nasdaq9d
Patterson-UTI Energy (PTEN) Shares Cross Above 200 DMA
In trading on Tuesday, shares of Patterson-UTI Energy Inc. (Symbol: PTEN) crossed above their 200 day moving average of $9.09, changing hands as high as $9.28 per share. Patterson-UTI Energy Inc ...
MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...